<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="66859">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02235454</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00056471</org_study_id>
    <nct_id>NCT02235454</nct_id>
  </id_info>
  <brief_title>SDOCT-GMPE Software</brief_title>
  <official_title>A Prospective Evaluation of the Novel Glaucoma Premium Edition Software for Spectral Domain Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators prospectively evaluate the new glaucoma premium edition (GMPE) software
      for spectral domain optical coherence tomography (SDOCT) and if this software is superior to
      the conventional one that is currently used for SDOCT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The new GMPE software can now identify the ocular structures without input from the operator
      thus reducing operator induced errors. It also measures the thickness of the entire optic
      nerve head so as to allow for another anatomic area of the eye to be measured for assessment
      of glaucoma. In addition, it permits collection of retinal nerve fiber layer thickness data
      in three concentric circles instead of just one in order to account for different sizes of
      optic nerves.

      Subjects who are receiving routine SDOCT (CPT 92133) will be recruited from the Duke Eye
      Center and its associated satellite clinics. Following informed consent, subjects undergo
      additional imaging using the SDOCT-GMPE software at the Duke Eye Center and its associated
      satellite clinics. The imaging results may be used in clinical care for the subjects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RNFL thickness</measure>
    <time_frame>day of imaging approximately 1 hour</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Glaucoma arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Consecutive patients with glaucoma will undergo non-invasive OCT imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SDOCT-GMPE software</intervention_name>
    <description>Noninvasive imaging of the optic nerve in patients with existing glaucoma</description>
    <arm_group_label>Glaucoma arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  capable and willing to provide consent

          -  history of clinically-diagnosed glaucoma

          -  at least 18 years of age

        Exclusion Criteria:

          -  unable or unwilling to give consent

          -  under 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjay Asrani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke Eye Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjay Asrani, MD</last_name>
      <phone>919-684-2841</phone>
      <email>sanjay.asrani@duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Garrick Chak, MD</last_name>
      <phone>919-684-2841</phone>
      <email>garrick.chak@duke.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 5, 2016</lastchanged_date>
  <firstreceived_date>September 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <keyword>OCT</keyword>
  <keyword>spectral domain optical coherence tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
